News & Updates

Show Multimedia Only

Cagrilintide-semaglutide tied to weight loss in adults with obesity, T2D

30 Oct 2025 by

Combination treatment with cagrilintide and semaglutide significantly reduced body weight in patients with overweight or obesity and type 2 diabetes (T2D), according to the REDEFINE 2 trial presented at EASD 2025.

Cagrilintide-semaglutide tied to weight loss in adults with obesity, T2D

30 Oct 2025

Metformin helps reduce ADT-related complications in prostate cancer patients

29 Oct 2025 by

Metformin seems inadequate in reducing the risk of metabolic syndrome (MS) in patients with prostate cancer receiving androgen deprivation therapy (ADT), results of the PRIME study have shown.

Metformin helps reduce ADT-related complications in prostate cancer patients

29 Oct 2025

Obesity linked to COVID-19 severity in children during pre-Omicron wave

28 Oct 2025 by

A recent study has found that individuals with obesity had more severe COVID-19 during the ancestral and pre-Omicron waves, but not during the Omicron wave.

Obesity linked to COVID-19 severity in children during pre-Omicron wave

28 Oct 2025

Young-onset diabetes: Novel insights on management

28 Oct 2025 by

At EmW 2025, Professor Andrea Luk from the Department of Medicine & Therapeutics, the Chinese University of Hong Kong, shared insights and recommendations on management of young-onset diabetes (YoD).

Young-onset diabetes: Novel insights on management

28 Oct 2025

Ovarian steroid addback increases symptom severity in women with PMDD

27 Oct 2025

Ovarian hormone suppression gets rid of symptom cyclicity in women with premenstrual dysphoric disorder (PMDD), reports a study. In addition, ovarian steroid addback results in the emergence of symptoms in those with PMDD but not in healthy comparison women.

Ovarian steroid addback increases symptom severity in women with PMDD

27 Oct 2025

Gestational diabetes tied to increased CVD risks

26 Oct 2025

Women with gestational diabetes are at heightened risks of overall and specific cardiovascular diseases (CVDs), including chronic hypertension, according to a nationwide population‐based cohort study.

Gestational diabetes tied to increased CVD risks

26 Oct 2025

Semaglutide, tirzepatide equally effective in cardiometabolic HFpEF

25 Oct 2025

Semaglutide is as good as tirzepatide in the treatment of patients with cardiometabolic heart failure with preserved ejection fraction (HFpEF), with both drugs yielding substantial reduction in the risks of cardiac hospitalization and mortality compared with sitagliptin, as reported in a study.

Semaglutide, tirzepatide equally effective in cardiometabolic HFpEF

25 Oct 2025

[Infographics] Expanding roles of semaglutide in CKM syndrome

23 Oct 2025

Semaglutide is a key organ-protective medication for managing cardio-kidney-metabolic (CKM) syndrome. Discover more about positive trial results across seven key components of CKM syndrome, and upcoming data on semaglutide.

[Infographics] Expanding roles of semaglutide in CKM syndrome

23 Oct 2025

Mangoes serve up metabolic health benefits for adults with prediabetes

22 Oct 2025 by

Eating mangoes daily may help with glycaemic control, insulin sensitivity, and body composition in adults with prediabetes, as shown in a study.

Mangoes serve up metabolic health benefits for adults with prediabetes

22 Oct 2025

What characterizes patients with PTDM?

22 Oct 2025

Patients with post-transplantation diabetes mellitus (PTDM) tend to be older and have higher BMI, triglyceride levels, and hypertension, according to a study.

What characterizes patients with PTDM?

22 Oct 2025

News & Updates

Filter by Specialty:

Specialty:

Cagrilintide-semaglutide tied to weight loss in adults with obesity, T2D

Cagrilintide-semaglutide tied to weight loss in adults with obesity, T2D

Metformin helps reduce ADT-related complications in prostate cancer patients

Metformin helps reduce ADT-related complications in prostate cancer patients

Obesity linked to COVID-19 severity in children during pre-Omicron wave

Obesity linked to COVID-19 severity in children during pre-Omicron wave

Young-onset diabetes: Novel insights on management

Young-onset diabetes: Novel insights on management

Ovarian steroid addback increases symptom severity in women with PMDD

Ovarian steroid addback increases symptom severity in women with PMDD

Gestational diabetes tied to increased CVD risks

Gestational diabetes tied to increased CVD risks

Semaglutide, tirzepatide equally effective in cardiometabolic HFpEF

Semaglutide, tirzepatide equally effective in cardiometabolic HFpEF

[Infographics] Expanding roles of semaglutide in CKM syndrome

[Infographics] Expanding roles of semaglutide in CKM syndrome

Mangoes serve up metabolic health benefits for adults with prediabetes

Mangoes serve up metabolic health benefits for adults with prediabetes

What characterizes patients with PTDM?

What characterizes patients with PTDM?